Using liver cell cultures derived from human pluripotent stem cells, the effect of the PNPLA3 148M variant causing a NAFLD phenotype was reproduced and linked to increased NF-kB and interleukin 6 activity [37]. This evidence concerns the gene PNPLA3 and metabolic dysfunction-associated steatotic liver disease.